8 results
DEF 14A
PROK
ProKidney Corp - Ordinary Shares
26 May 23
Definitive proxy
8:00am
the past five years, the length of their tenure as directors and the names of other public companies in which such persons hold or have held
8-K
EX-3.1
PROK
ProKidney Corp - Ordinary Shares
15 Jul 22
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq
5:24pm
of the Company during their tenure of office at the next annual general meeting following their appointment in the case of a company which
DEFA14A
PROK
ProKidney Corp - Ordinary Shares
21 Jan 22
Additional proxy soliciting materials
4:38pm
or her tenure of any such other office or place of profit or as vendor, purchaser or otherwise.
In particular, neither shall:
any contract
8-K/A
EX-2.1
PROK
ProKidney Corp - Ordinary Shares
21 Jan 22
Entry into a Material Definitive Agreement
4:33pm
office from contracting with the Company either with regard to his or her tenure of any such other office or place of profit or as vendor, purchaser … on the accounts of the Company during their tenure of office at the next annual general meeting following their appointment in the case of a company
8-K
EX-3.1
x8o4hd9bcrx71gh
2 Jul 21
Social Capital Suvretta Holdings Corp. III Announces Pricing of Upsized $220,000,000 Initial Public Offering
4:22pm
S-1
EX-3.1
xj333zzuegvx004c
2 Jun 21
IPO registration
5:17pm
S-1
EX-3.2
wvuizgqr8wbgdd6s
2 Jun 21
IPO registration
5:17pm
- Prev
- 1
- Next